scispace - formally typeset
C

Claudine Legault

Researcher at Wake Forest University

Publications -  59
Citations -  8544

Claudine Legault is an academic researcher from Wake Forest University. The author has contributed to research in topics: Randomized controlled trial & Estrogen. The author has an hindex of 31, co-authored 59 publications receiving 8076 citations. Previous affiliations of Claudine Legault include University of Texas Medical Branch & Royal North Shore Hospital.

Papers
More filters
Journal ArticleDOI

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

Valery T. Miller, +94 more
- 18 Jan 1995 - 
TL;DR: Estrogen alone or in combination with a progestin improves lipoproteins and lowers fibrinogen levels without detectable effects on postchallenge insulin or blood pressure and in women with a uterus, CEE with cyclic MP has the most favorable effect on HDL-C and no excess risk of endometrial hyperplasia.
Journal ArticleDOI

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

TL;DR: Estrogen plus progestin therapy increased the risk for probable dementia in postmenopausal women aged 65 years or older and did not prevent mild cognitive impairment in these women, supporting the conclusion that the risks of estrogen plus progESTin outweigh the benefits.
Journal ArticleDOI

Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

TL;DR: The Postmenopausal Estrogen/Progestin Interventions Trial, a randomized, placebo-controlled trial of the effects of 4 hormone preparations on cardiovascular disease risk factors, found postmenopausal hormones rapidly increased the concentration of the inflammation factor C-reactive protein.